PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home »

Psychiatric Times. Vol. 26 No. 9
Pages: 1  2  
Previous
MOLECULES OF THE MIND 

The Teenaged Brain: Part 2

By John J. Medina, PhD | September 3, 2009
Dr Medina is a developmental molecular biologist and private consultant, with research interests in the genetics of psychiatric disorders. For more on Dr Medina visit http://brainrules.net/.

RISK TAKING AND SUBSTANCE ABUSE

Epidemiological studies clearly point to the fact that adolescents are more likely to experiment with controlled substances than any other age-group. Do any of the statistics reflect underlying mental health issues? Certainly some forms of substance abuse are associated with behavioral anomalies during childhood. Are any of these anomalies associated with mental disorders?

Research into questions like these can be difficult to perform and for a single reason: from lemurs to humans, typical, normally developing adolescence is associated with a rich increase in novelty-seeking and risk-taking behaviors. There are certainly evolutionary reasons why this might be so. Creating behavioral firewalls between otherwise well-associated groups is a great way to keep newly reproductively competent adolescents from mating within the natal clan. (A willingness to leave the group and find other non-consanguineous clans with whom to mate would ensure greater genetic diversity). The probability of actually exiting the safety of home would be greatly aided by a healthy desire for novelty seeking and risk taking. That, in turn, would increase the genetic diversity of mating opportunities.

If that were the case, you might hypothesize that the activity of regions of the brain involved in rewarding risk taking might be more active in adolescents than in adults. And that those adolescents who were born with a pathologically heightened need for thrill seeking might be more susceptible to dangerous behavior of any kind, including substance abuse.

Are there any genetic explanations for these ideas? There certainly is a gene that has over the years become associated with risk-taking behavior. The sequence is called neuroD2 and is expressed in various regions of the brain, including the amygdala. Its relationship with specific alterations in teenaged behavior in humans is ambiguous, however, and awaits further research. And perhaps clarification.

One way to think of changes in behavioral risk is not to think of neuroD2-like behaviors at all. One could just as easily speculate that adolescents have less aversive reactions to the negative biological consequences of their behaviors—such as drugs normally associated with substance abuse.

Such changes are certainly true in laboratory animals. Adolescent mice are astonishingly more insensitive to the motor impairments normally associated with alcohol(Drug information on alcohol) ingestion than are older animals. They are not as easily sedated as adult controls and get less of a hangover too. There is evidence that the developmental immaturity of our familiar GABAA receptor in adolescent mice brains is in part responsible for these changes.

Researchers have also looked to noninvasive imaging experiments in an attempt to explain increases in risk-taking behavior. Deploying a series of monetary-reward tasks in conjunction with fMRI, some initially promising work examining both adolescent and adult subjects was done. Specifically, adolescents possess greater reward feedback–related activity than older persons. The focus was initially on the nucleus accumbens, which as you may recall, is largely associated with reward behavior. The researchers found greater activity in response to monetary gains in adolescents than they did in young adults.

Unfortunately, not all researchers were able to replicate these findings. Indeed, some investigators showed just the opposite: that nucleus accumbens activity is actually reduced in adolescents in response to financial-gain experiments when compared with controls.

How to think about these data? It is reasonable to assume that certain neural alterations occurring during adolescence would predispose those populations to risky behavior. But exactly what those differences are is a matter of great debate. In most cases, the jury is out—way out—in both applying what we see in mice to humans and to understanding exactly what is occurring in the adolescent brain when it is being imaged. From a research perspective, the devil is in the midpubertal details.

And that, perhaps, is a lesson. No one will argue that adolescence is a time of great change. Powerful hormones unleashing equally powerful behavioral forces get to accomplish the brain’s ultimate reason for living: to supply humanity’s next generation with a next generation. But as I hoped to have illustrated here, we are a long way from being able to understand exactly what those changes are. We are even further from understanding how those changes link to observable behavior and how that understanding will help us explain the NCS-R age-onset data.

At the end of the day, the most important contribution these data give us is to provide a reassuring—even tantalizing—framework for asking the right research questions. Something is going on in a brain under assault by puberty. If we could only just discover what the psychiatric anomalies were telling us, we might have greater insight into what happens normally. Finally, we might begin to understand what is going on in the minds of our adolescents—a hope no doubt echoed by every researcher interested in the biological basis of puberty.

And, perhaps, by every family who has ever had to experience the mixed blessing of sharing a household with an adolescent.

Pages: 1  2  
Previous
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 


 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Developmental Psychopathology Comes of Age
  • The Moral Struggles of Practicing Psychiatrists
  • Grief and Depression: The Sages Knew the Difference
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Grief and Depression: The Sages Knew the Difference
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Developmental Psychopathology Comes of Age
  • Psychiatry and the Myth of “Medicalization”
  • Will Your Clinical Records Support You in Court?
  • Refinements in ECT Techniques
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • Capacity Evaluation in Geriatric Psychiatry: Key Ingredients
  • Eco-Psychiatry: Why We Need to Keep the Environment in Mind
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • Diagnosis and its Discontents: The DSM Debate Continues
  • Lamotrigine for Major Depressive Disorder Is Inappropriate
  • New Insight Into the Neurobiology of Depression
  • Tie One On for Patients
  • NIMH vs DSM 5: No One Wins, Patients Lose
  • Psychiatry and the Myth of “Medicalization”
  • Parity Laws: Powerful Weapon—or Pipe Dream?
Click here to subscribe to our newsletter
 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry
 
SearchMedica SEARCH RESULT

Find peer-reviewed literature and websites for practicing medical professionals

CME on Display
Evidence on Display
Guidelines on Display
Patient Education on Display
Clinical Trials on Display
Practical Articles on Display
Research and Reviews on Display
All "Display" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy